Scott S. Auerbach Division of the National Toxicology Program, National
Institute of Environmental Health Sciences, National Institutes of Health, Durham,
NC, USA
Daniel Bachler Edelweiss Connect GmbH, Technology Park Basel, Basel,
Switzerland
Chris Barber Lhasa Limited, Leeds, UK
Emilio Benfenati Istituto di Ricerche Farmacologiche Mario Negri – IRCCS,
Milano, Italy
Richard Bergström Bergstroem Consulting GmbH, Zug, Switzerland
Jürgen Borlak Hannover Medical School, Center of Pharmacology and
Toxicology, Hannover, Germany
Daniel Burgwinkel Guardtime AS, Basel, Switzerland
Alex Cayley Lhasa Limited, Leeds, UK
Jingwen Chen Key Laboratory of Industrial Ecology and Environmental
Engineering (Ministry of Education), School of Environmental Science and
Technology, Dalian University of Technology, Dalian, China
Minjun Chen Division of Bioinformatics and Biostatistics, National Center for
Toxicological Research, US Food and Drug Administration (FDA), Jefferson, AR,
USA
Feixiong Cheng Genomic Medicine Institute, Lerner Research Institute,
Cleveland Clinic, Cleveland, OH, USA;
Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine,
Case Western Reserve University, Cleveland, OH, USA;
Case Comprehensive Cancer Center, Case Western Reserve University School of
Medicine, Cleveland, OH, USA
Martyn Chilton Lhasa Limited, Leeds, UK
Brian Delavan Division of Bioinformatics and Biostatistics, National Center for
Toxicological Research, US Food and Drug Administration (FDA), Jefferson, AR,
USA;
Department of Biosciences, University of Little Rock, Little Rock, AR, USA
Joh Dokler Edelweiss Connect GmbH, Technology Park Basel, Basel,
Switzerland
Thomas Exner Edelweiss Connect GmbH, Technology Park Basel, Basel,
Switzerland
Lilia Fisk Lhasa Limited, Leeds, UK
xiv
Editor and Contributors
Précédent

- 14/416

Suivant